EP 1370255 A2 20031217 - CDC25 PHOSPHATASE INHIBITORS
Title (en)
CDC25 PHOSPHATASE INHIBITORS
Title (de)
CDC25 PHOSPHATASE INHIBITOREN
Title (fr)
INHIBITEURS DE PHOSPHATASES CDC25
Publication
Application
Priority
- FR 0102443 W 20010726
- FR 0009900 A 20000728
Abstract (en)
[origin: WO0209686A2] The invention concerns novel cdc25 phosphatase inhibitors, and in particular cdc25-C, which correspond to the general formula (I) wherein: A represents a carbocyclic aryl radical optionally substituted 1 to 3 times by one or more radicals independently selected among a halogen atom and an alkyl, hydroxy, alkoxy, alkylthio or NR<1>R<2> radical wherein R<1> and R<2> represent a hydrogen atom or an alkyl radical or R<1> and R<2> form together with the nitrogen atom a heterocycle of 4 to 7 members comprising 1 to 2 heteroatoms, the members required to complete the heterocycle being selected independently among the CR<3>R<4>-, -O-, -S and NR<5>- radicals, R<3> and R<4> representing independently each time they are involved a hydrogen atom or an alkyl, hydroxy, alkoxy, amino, alkylamino or dialkylamino radical, and R5 representing independently each time it is involved a hydrogen atom or an alkyl radical, or A represents a phenyl radical substituted by a phenyl radical optionally substituted 1 to 3 times by one or more radicals selected independently among a halogen atom and an alkyl, hydroxy, alkoxy, alkylthio or NR<1>R<2> radical wherein R<1> and R<2> represent a hydrogen atom or an alkyl radical; B represents a -(CH2)i-(CO)- or -NH-CO-(CH2)n or -(CH2)p and i and n being integers from 0 to 2 and p being an integer from 0 to 1; W represents a hydrogen atom or an alkyl radical; X represents a -(CH2)q- or (CH2)j-CO-(CH2)r-, q being an integer from 1 to 4 and j and r being integers from 0 to 6; Y represents in particular a nitrophenyl, aminophenyl, alkylaminophenyl or dialkylaminophenyl radical or the radical (T).
IPC 1-7
A61K 31/137; A61K 31/495; A61K 31/381; A61P 43/00; A61P 35/00; A61P 33/00; A61P 31/12; A61P 17/14
IPC 8 full level
A61K 31/04 (2006.01); A61K 31/137 (2006.01); A61K 31/166 (2006.01); A61K 31/18 (2006.01); A61K 31/222 (2006.01); A61K 31/24 (2006.01); A61K 31/381 (2006.01); A61K 31/4164 (2006.01); C07D 295/12 (2006.01); A61K 31/445 (2006.01); A61K 31/495 (2006.01); A61K 31/63 (2006.01); A61K 31/661 (2006.01); A61K 31/6615 (2006.01); A61P 17/14 (2006.01); A61P 21/00 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); A61P 31/12 (2006.01); A61P 33/00 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07C 69/157 (2006.01); C07C 211/53 (2006.01); C07C 215/78 (2006.01); C07C 215/80 (2006.01); C07C 217/84 (2006.01); C07C 229/36 (2006.01); C07C 235/66 (2006.01); C07C 303/38 (2006.01); C07C 311/08 (2006.01); C07C 311/13 (2006.01); C07C 311/21 (2006.01); C07C 311/29 (2006.01); C07C 311/37 (2006.01); C07D 211/96 (2006.01); C07D 233/84 (2006.01); C07D 241/04 (2006.01); C07D 295/135 (2006.01); C07D 295/155 (2006.01); C07D 295/192 (2006.01); C07D 295/26 (2006.01); C07D 333/22 (2006.01); C07D 333/34 (2006.01); C07D 333/38 (2006.01); C07F 9/12 (2006.01)
CPC (source: EP KR US)
A61K 31/137 (2013.01 - EP KR US); A61K 31/165 (2013.01 - EP US); A61K 31/18 (2013.01 - EP US); A61K 31/381 (2013.01 - EP US); A61K 31/445 (2013.01 - EP US); A61K 31/495 (2013.01 - EP US); A61K 31/63 (2013.01 - EP US); A61P 17/14 (2018.01 - EP); A61P 21/00 (2018.01 - EP); A61P 25/00 (2018.01 - EP); A61P 25/28 (2018.01 - EP); A61P 31/12 (2018.01 - EP); A61P 33/00 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 35/02 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07C 217/84 (2013.01 - EP US); C07C 229/36 (2013.01 - EP US); C07C 235/66 (2013.01 - EP US); C07C 311/08 (2013.01 - EP US); C07C 311/13 (2013.01 - EP US); C07C 311/21 (2013.01 - EP US); C07C 311/29 (2013.01 - EP US); C07C 311/37 (2013.01 - EP US); C07D 233/84 (2013.01 - EP US); C07D 295/135 (2013.01 - EP US); C07D 295/192 (2013.01 - EP US); C07D 295/26 (2013.01 - EP US); C07D 333/22 (2013.01 - EP US); C07D 333/34 (2013.01 - EP US); C07F 9/12 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0209686 A2 20020207; WO 0209686 A3 20031009; AU 2001282234 B2 20060727; AU 2006233164 A1 20061109; AU 2006233164 B2 20081023; AU 8223401 A 20020213; BR 0112824 A 20040210; CA 2417262 A1 20020207; CN 100406449 C 20080730; CN 1474689 A 20040211; CZ 2003273 A3 20030618; EP 1370255 A2 20031217; EP 1602368 A2 20051207; EP 1602368 A3 20090902; FR 2812198 A1 20020201; FR 2812198 B1 20080718; HK 1063016 A1 20041210; HU P0303828 A2 20040301; HU P0303828 A3 20071029; IL 153999 A0 20030731; IL 153999 A 20070704; IS 6701 A 20030127; JP 2004506618 A 20040304; KR 20030020414 A 20030308; MX PA03000860 A 20030606; NO 20030421 D0 20030127; NO 20030421 L 20030319; NZ 523739 A 20050930; PL 365074 A1 20041227; RU 2285521 C2 20061020; US 2004034103 A1 20040219; US 2006154933 A1 20060713; US 2006235027 A1 20061019; US 7196084 B2 20070327
DOCDB simple family (application)
FR 0102443 W 20010726; AU 2001282234 A 20010726; AU 2006233164 A 20061024; AU 8223401 A 20010726; BR 0112824 A 20010726; CA 2417262 A 20010726; CN 01814954 A 20010726; CZ 2003273 A 20010726; EP 01960837 A 20010726; EP 05018614 A 20010726; FR 0009900 A 20000728; HK 04105845 A 20040806; HU P0303828 A 20010726; IL 15399901 A 20010726; IL 15399903 A 20030116; IS 6701 A 20030127; JP 2002515239 A 20010726; KR 20037001208 A 20030127; MX PA03000860 A 20010726; NO 20030421 A 20030127; NZ 52373901 A 20010726; PL 36507401 A 20010726; RU 2003105689 A 20010726; US 34317103 A 20030127; US 35069206 A 20060209; US 41065906 A 20060425